首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷體外診斷癌症癌症診斷

市場調查報告書

商品編碼

2126785

乳癌診斷市場：按診斷類型、最終用戶和地區分類

Breast Cancer Diagnostic Market, By Diagnostic Type, By End User, By Geography

出版日期: 2026年08月31日 | 出版商:

Coherent Market Insights | 英文 253 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，乳癌診斷市場規模將達到 64 億美元，到 2033 年將達到 118 億美元。預計 2026 年至 2033 年的複合年成長率將達到 8.9%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	64億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.90%	2033年市場規模預測：	118億美元

乳癌診斷市場涵蓋幫助醫療專業人員檢測、評估和後續觀察乳癌的技術和服務。主要診斷方法包括乳房X光檢查、超音波、磁振造影（MRI）、切片檢查和分子檢測。乳癌病例數量的增加、早期篩檢意識的提高以及診斷項目的擴展，都在推動對可靠解決方案的需求。醫學影像和生物標記檢測技術的進步，使臨床醫生能夠更早地識別癌症，提高診斷準確性，支持個人化治療決策，並改善患者預後。

技術創新正在透過提高影像品質、工作流程效率和檢測準確性來變革乳癌診斷。醫療機構正在採用數位乳房X光攝影、 3D乳房攝影影像、人工智慧（AI）輔助篩檢和分子診斷技術。對醫療基礎設施和癌症篩檢舉措的投資正在改善診斷服務的可近性，尤其是在新興經濟體。製造商正在開發先進的平台，以實現更快的分析和更準確的疾病特徵分析，從而為醫院、診斷檢查室、影像中心和專科癌症治療機構創造新的機會。

市場動態

由於乳癌病例的增加以及醫療機構對早期檢測的日益重視，乳癌診斷市場正在擴張。各國政府和醫療機構正在加強篩檢計畫和宣傳宣傳活動，以促進及時診斷。醫療保健支出的成長和診斷設施可近性的提高也支撐了市場需求。乳房X光檢查、超音波、磁振造影（MRI）和切片檢查技術的進步使臨床醫生能夠更準確地識別異常情況。高風險族群常規篩檢的增加進一步推動了先進診斷解決方案的應用。

技術創新正在為乳癌診斷市場創造新的機會。製造商正採用人工智慧 (AI)、 3D成像、數位乳房X光攝影和分子診斷技術來提高檢測能力和臨床決策水平。人工智慧成像技術有助於放射科醫生識別可疑病灶並簡化工作流程。生物標記和基因組檢測能夠對腫瘤進行詳細表徵，並支持制定個人化治療方案。研發投入的增加也促使製造商開發速度更快、更準確、更創傷的診斷技術。

該市場面臨許多挑戰，例如設備成本高昂、先進診斷設施有限、監管要求複雜以及熟練專業人員短缺。這些障礙可能會阻礙發展中地區和醫療服務不足地區的技術普及。對假陽性結果、輻射暴露、資料隱私和診斷準確性的擔憂也會影響該技術的推廣應用。然而，醫療基礎設施的不斷改進、政府主導的篩檢計畫、遠端醫療以及對人工智慧和分子診斷領域投資的增加，正為全球製造商和醫療服務提供者帶來新的機會。

本次調查的主要特點

該研究重點關注各個細分市場的潛在商機，並為參與乳癌診斷市場的相關人員提供了一個有吸引力的投資提案矩陣。
本研究深入分析了市場促進因素、限制因素、機會、新興技術、診斷技術創新、人工智慧應用、先進成像技術、篩檢趨勢、分子診斷、區域展望以及主要市場參與企業採取的競爭策略。
本研究根據公司簡介、產品系列、近期發展、技術進步、財務表現和策略舉措，對乳癌診斷市場的主要參與者進行了分析。
透過利用本報告中提出的見解，醫療保健提供者、診斷實驗室、放射科醫生、腫瘤科醫生、投資者、技術開發人員和經營團隊可以就診斷技術的採用、產品開發、技術投資、市場擴張、戰略合作夥伴關係和癌症篩檢計畫做出明智的決策。
這份「乳癌診斷市場」報告的目標相關人員廣泛，包括投資者、醫療設備製造商、診斷公司、醫院、影像中心、研究機構、醫療保健提供者、經銷商、新參與企業和金融分析師。
相關人員可以透過「乳癌診斷市場」報告中提出的分析框架、競爭基準、技術評估、產品評估和市場評估矩陣做出明智的策略決策。

利用電離輻射的乳房攝影成像技術
模擬乳房攝影
全視野數位乳房X光乳房X光攝影（FFDM）
3D乳房斷層合成
正子斷層掃描/電腦斷層掃描（PET/CT）
分子乳房影像/乳房特異性伽瑪成像（MBI/BSMI）
正電子放射乳房攝影術
其他
非電離成像技術
乳癌磁振造影（MRI）
乳腺超音波檢查
光學成像
自動全乳超音波（AWBU）
乳房熱成像

第5章全球乳癌診斷市場：依最終用戶分類，2021-2033年

醫院
癌症研究中心/研究所
診斷和臨床實驗室
門診手術中心

第6章全球乳癌診斷市場：依地區分類，2021-2033年

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Hologic Inc.
- GE Healthcare
- Phillips Healthcare
- Fujifilm Holdings Corporation
- Gamma Medica Inc.
- Toshiba Corporation
- Aurora Imaging Technology Inc.
- Dilion Technologies Inc.
分析師意見

第8章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI425

Breast Cancer Diagnostic Market is estimated to be valued at USD 6.4 Bn in 2026 and is expected to reach USD 11.8 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 6.4 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.90%	2033 Value Projection:	USD 11.8 Bn

The Breast Cancer Diagnostic Market covers technologies and services that help healthcare professionals detect, assess, and monitor breast cancer. Major diagnostic approaches include mammography, ultrasound, magnetic resonance imaging, biopsy, and molecular testing. Increasing breast cancer cases, greater awareness of early screening, and expanding diagnostic programs are driving demand for reliable solutions. Advances in medical imaging and biomarker testing help clinicians identify cancer earlier, improve diagnostic accuracy, guide personalized treatment decisions, and enhance patient outcomes.

Technological innovation is reshaping breast cancer diagnosis by enhancing imaging quality, workflow efficiency, and detection accuracy. Healthcare providers are adopting digital mammography, three-dimensional breast imaging, artificial intelligence-assisted screening, and molecular diagnostic technologies. Investments in healthcare infrastructure and cancer screening initiatives are improving access to diagnostic services, especially in emerging economies. Manufacturers are developing advanced platforms that enable faster analysis and more accurate disease characterization, creating new opportunities across hospitals, diagnostic laboratories, imaging centers, and specialized cancer facilities.

Market Dynamics

The Breast Cancer Diagnostic Market is expanding as breast cancer cases rise and healthcare providers place greater emphasis on early detection. Governments and healthcare organizations are strengthening screening programs and awareness campaigns to promote timely diagnosis. Higher healthcare spending and better access to diagnostic facilities are also supporting demand. Advances in mammography, ultrasound, magnetic resonance imaging, and biopsy technologies enable clinicians to identify abnormalities more accurately. Increasing routine screening among high-risk groups further drives adoption of advanced diagnostic solutions.

Technological innovation is creating new opportunities in the Breast Cancer Diagnostic Market. Manufacturers are incorporating artificial intelligence, three-dimensional imaging, digital mammography, and molecular diagnostics to enhance detection and clinical decision-making. AI-assisted imaging helps radiologists identify suspicious lesions and improve workflow efficiency. Biomarker and genomic testing provide detailed tumor characterization and support personalized treatment planning. Growing research and development investments are also encouraging manufacturers to develop faster, more accurate, and minimally invasive diagnostic technologies.

The market faces challenges such as high equipment costs, limited access to advanced diagnostic facilities, complex regulatory requirements, and shortages of skilled professionals. These barriers can limit adoption across developing and underserved regions. False-positive results, radiation exposure, data privacy concerns, and diagnostic accuracy issues may also affect technology adoption. However, healthcare infrastructure expansion, government-led screening programs, telemedicine, and increased investment in artificial intelligence and molecular diagnostics are opening new opportunities for manufacturers and healthcare providers worldwide.

Key Features of the Study

It highlights potential revenue opportunities across various market segments and provides attractive investment proposition matrices for stakeholders involved in the Breast Cancer Diagnostic Market.
This study offers key insights into market drivers, restraints, opportunities, emerging technologies, diagnostic innovations, artificial intelligence applications, advanced imaging technologies, screening trends, molecular diagnostics, regional outlook, and competitive strategies adopted by leading market participants.
It profiles key players in the Breast Cancer Diagnostic Market based on company overview, product portfolio, recent developments, technological advancements, financial performance, and strategic initiatives.
Key companies covered as part of this study include Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Illumina, Inc., and Canon Medical Systems Corporation.
Insights from this report enable healthcare providers, diagnostic laboratories, radiologists, oncologists, investors, technology developers, and management teams to make informed decisions regarding diagnostic technology adoption, product development, technology investments, market expansion, strategic collaborations, and cancer screening initiatives.
The Breast Cancer Diagnostic Market report serves a wide range of stakeholders, including investors, medical device manufacturers, diagnostic companies, hospitals, imaging centers, research organizations, healthcare providers, distributors, new market entrants, and financial analysts.
Stakeholders can make well-informed strategic decisions through the analytical frameworks, competitive benchmarking, technology assessment, product evaluation, and market evaluation matrices presented in the Breast Cancer Diagnostic Market report.

Market Segmentation

By Diagnostic Type (Revenue, USD Bn, 2021-2033)
Ionizing breast imaging technologies
- Analog Mammography
- Full-field digital mammography (FFDM)
- 3D breast tomosynthesis
- Positron emission tomography/ Computed tomography (PET/CT)
- Molecular Breast imaging/ breast specific gamma imaging (MBI/BSMI)
- Positron emission mammography
- Others
Non-ionizing imaging technologies:
- Breast MRI (Magnetic Resonance Imaging)
- Breast Ultrasound
- Optical Imaging
- Automated whole breast ultrasound (AWBU)
- Breast thermography
By End User (Revenue, USD Bn, 2021-2033)
Hospitals
Cancer research centers/ institutes
Diagnostic Clinical laboratories
Ambulatory Surgical centers
By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
Hologic Inc.
GE Healthcare
Phillips Healthcare
Fujifilm Holdings Corporation
Gamma Medica Inc.
Toshiba Corporation
Aurora Imaging Technology Inc.
Dilion Technologies Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Diagnostic Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Breast Cancer Diagnostic Market, By Diagnostic Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Ionizing breast imaging technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Segment Trends
Analog Mammography
Full-field digital mammography (FFDM)
3D breast tomosynthesis
Positron emission tomography/ Computed tomography (PET/CT)
Molecular Breast imaging/ breast specific gamma imaging (MBI/BSMI)
Positron emission mammography
Others
Non-ionizing imaging technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Segment Trends
Breast MRI (Magnetic Resonance Imaging)
Breast Ultrasound
Optical Imaging
Automated whole breast ultrasound (AWBU)
Breast thermography

5. Global Breast Cancer Diagnostic Market, By End User, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Cancer research centers/ institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Diagnostic Clinical laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Ambulatory Surgical centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Breast Cancer Diagnostic Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Hologic Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- GE Healthcare
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Phillips Healthcare
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Fujifilm Holdings Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Gamma Medica Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Toshiba Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Aurora Imaging Technology Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Dilion Technologies Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views